Fri, August 10, 2018
Thu, August 9, 2018
Wed, August 8, 2018
Tue, August 7, 2018
Mon, August 6, 2018
Fri, August 3, 2018
Thu, August 2, 2018
Wed, August 1, 2018
Tue, July 31, 2018
Mon, July 30, 2018

Matthew Harrison Maintained (BMRN) at Buy with Increased Target to $115 on, Aug 3rd, 2018


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-115-on-aug-3rd-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $113 to $115 on, Aug 3rd, 2018.

Matthew has made no other calls on BMRN in the last 4 months.



There are 4 other peers that have a rating on BMRN. Out of the 4 peers that are also analyzing BMRN, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Matthew


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $113 on, Tuesday, July 31st, 2018
  • M. Auster of "Credit Suisse" Maintained at Buy with Increased Target to $122 on, Monday, July 9th, 2018
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $133 on, Thursday, May 31st, 2018
  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $115 on, Tuesday, May 29th, 2018

Publication Contributing Sources